Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D2GJ | ISIN: US67644C1045 | Ticker-Symbol: 8AW0
Stuttgart
27.06.25 | 21:33
0,008 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
OCEAN BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
OCEAN BIOMEDICAL INC 5-Tage-Chart

Aktuelle News zur OCEAN BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.06.Ocean Biomedical drohen Lizenzbeendigungen wegen Vertragsverletzungen7
13.06.Ocean Biomedical, Inc. - 8-K, Current Report5
15.05.Ocean Biomedical, Inc. - 10-Q, Quarterly Report9
06.05.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 06.05.2025407The following instruments on Boerse Frankfurt do have their last trading day on 06.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 06.05.2025ISIN NameAU000000AML5 AEON...
► Artikel lesen
23.04.Ocean Biomedical, Inc. - 8-K, Current Report15
22.04.Ocean Biomedical expands into energy and digital asset sectors6
08.04.Ocean Biomedical, Inc. - 10-K, Annual Report6
OCEAN BIOMEDICAL Aktie jetzt für 0€ handeln
01.04.Ocean Biomedical, Inc. - 8-K, Current Report5
01.04.Ocean Biomedical, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4054
28.03.Ocean Biomedical erhält wichtiges Patent in China für Krebstherapie21
28.03.Ocean Biomedical secures key patent in China for cancer therapy2
28.03.Ocean Biomedical, Inc.: Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China201PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company dedicated to advancing innovative treatments for cancer, infectious diseases...
► Artikel lesen
20.03.Ocean Biomedical, Inc. - 8-K, Current Report5
10.03.Ocean Biomedical, Inc. - 8-K, Current Report3
21.02.Ocean Biomedical, Inc. - 8-K, Current Report4
12.02.Ocean Biomedical, Inc. - 8-K, Current Report12
10.02.Ocean Biomedical, Inc.: Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development351Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest Providence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) today announced newly published...
► Artikel lesen
29.01.Ocean Biomedical, Inc.: Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway427Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received...
► Artikel lesen
13.01.Ocean Biomedical, Inc. - 10-Q, Quarterly Report7
22.11.24Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q226PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1